Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Mitochondrial immobilization mediated by syntaphilin facilitates survival of demyelinated axons.
The story of neuromyelitis optica continues to be written.
Habitual Functional Electrical Stimulation Therapy Improves Gait Kinematics and Walking Performance, but Not Patient-Reported Functional Outcomes, of People with Multiple Sclerosis who Present with Foot-Drop.
Neuropsychological features in childhood and juvenile multiple sclerosis: Five-year follow-up.
Diagnostic accuracy of neurophysiological criteria for early diagnosis of AIDP: A prospective study.
Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice.
Treatment Adherence and Transitioning Youth in Pediatric Multiple Sclerosis.
Oligodendrocytes: Myelination and Axonal Support.
[Local reactions to disease-modifying drugs: pathogenesis and relationship to clinical effectiveness.]
Cost effectiveness of a pragmatic exercise intervention (EXIMS) for people with multiple sclerosis: economic evaluation of a randomised controlled trial.
A new model for primary-progressive multiple sclerosis?
[Cognitive deficits and dementia in patients with multiple sclerosis: status quo and open questions].
Autoimmune T-Cell Reactivity to Myelin Proteolipids and Glycolipids in Multiple Sclerosis.
Off-pump coronary surgery in a patient with multiple sclerosis.
Functional brain imaging: an evidence-based analysis.
Bilateral Multifocal Chorioretinitis and Optic Neuritis due to Epstein-Barr Virus: A Case Report.
Six-year follow-up of a case series with non-communicating syringomyelia in multiple sclerosis.
Soluble CD146 in cerebrospinal fluid of active multiple sclerosis.
Pharmacodynamic Consequences of Administration of VLA-4 Antagonist CDP323 to Multiple Sclerosis Subjects: A Randomized, Double-Blind Phase 1/2 Study.
Mean Contact Quotient Using Electroglottography in Patients With Multiple Sclerosis.
Remission of Severe Myasthenia Gravis After Massive-Dose Vitamin D Treatment.
Altered resting-state functional connectivity in cognitively preserved pediatric-onset MS patients and relationship to structural damage and cognitive performance.
The miR-30a Negatively Regulates IL-17-Mediated Signal Transduction by Targeting Traf3ip2.
Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome Array.
The impact of pontine disease on lower urinary tract symptoms in patients with multiple sclerosis.
Pages
« first
‹ previous
…
392
393
394
395
396
397
398
399
400
…
next ›
last »